Proclarix is an easy to use simple protein-based blood test that can be done with the same sample as the PSA test. No additional intervention is required with results becoming quickly available. Using Proclarix reduces the number of biopsies needed to reliably detect clinically significant prostate cancer. Diagnosis without the risk, pain or costs of tissue biopsies. Patients with a PSA level between 2 and 10 ng/ml are in a diagnostic grey zone. Proclarix helps doctors and patients with PSA levels in the grey zone. Its Proclarix Risk Score delivers clear and immediate diagnostic support for further treatment decisions.